ABVC BioPharma, Inc. (ABVC)

R&D Expense Growth

-31.40%

Quarterly · Period ending:

ABVC logo

ABVC R&D Expense Growth

Latest reported-31.40%
ABVC Quarterly R&D Growth (QoQ) (0.00% → -31.40%)
High-resolution chart · PNG

ABVC r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

ABVC BioPharma, Inc. R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-31.3988%
13.9101%
-2.7835%
-10.1755%
15.2975%
-9.753%
-15.4527%
-6.3761%
-41.5038%
-4.3208%
-48.9173%
-72.5314%
53.5744%
-77.6052%
389.6469%
-42.6627%
48.2404%
38.1324%
-1.2284%
-26.5979%
195.8233%
-33.8104%
36.2696%
-3.2937%
49.889%
-65.5809%
0.13%
206.7587%
-79.1995%
-32.9589%
1,054.564%
-3.8503%
-77.1485%
442.9006%
-98.538%
17,762.6514%
-30.4175%
-0.1905%
-99.748%
0%
-100%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.